Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2005
12/14/2005CN1708269A Compositions and methods for transdermal oxybutynin therapy
12/14/2005CN1708268A Disposable pharmaceutical or cosmetic product applicator packaging
12/14/2005CN1706367A Capsule covering containing ass-hide gelatin component and its prepn process and application
12/14/2005CN1706366A Breath freshening tablet
12/14/2005CN1706365A Reversibly hot gelified water soluble medicine composition
12/14/2005CN1231493C Amphoteric sterols and the use thereof
12/14/2005CN1231477C Potassium salt of (I(S))-omeprazole
12/14/2005CN1231264C Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan
12/14/2005CN1231262C Mimetic peptides for epitope of apolipoprotein B-100, concatemer and modified peptides, and vaccine composition comprising the same
12/14/2005CN1231261C Compound alliin enteric solubility capsule
12/14/2005CN1231256C Non-aqueous proton peptide formulations
12/14/2005CN1231243C Medicinal recipe for treating rheumatalgia
12/14/2005CN1231240C Rose and donkey-hide gelatin syrup and its preparation
12/14/2005CN1231231C Ointment for treating burns and scalds and its prepn.
12/14/2005CN1231227C Making process of nanometer level pearl powder and shell powder
12/14/2005CN1231221C Process for producing Liposome injection liquid of hydrochloric acid daunerubicin
12/14/2005CN1231219C Huangyangning slow-releasing preparation
12/14/2005CN1231218C Use of medicinal composition in preparing medicine for treating middle ear infections
12/14/2005CN1231216C Aspartic acid lomefloxacin powder and preparing method thereof
12/14/2005CN1231211C Microcapsule for treating urticaria and its preparing process
12/14/2005CN1231210C Progesterone capsule composition and preparation thereof
12/14/2005CN1231209C Ursolic acid poly lactic acid nano particle freeze dried powder injection and its preparation method
12/14/2005CN1231208C Pharmaceutical compositions
12/13/2005USRE38919 Injectable microfoam containing a sclerosing agent
12/13/2005US6974856 Polyethylene oxide-polyethyleneimine derivative able to form a coating film or polymeric micelle capable of stably encapsulating acidic drugs or substances; enhanced biocompatibility
12/13/2005US6974837 Compositions comprising sibutramine metabolites in combination with phosphodiesterase inhibitors
12/13/2005US6974832 L-ascorbic acid and pectin composition
12/13/2005US6974807 administering topically to alleviate proliferative skin diease; nontoxic
12/13/2005US6974699 Pharmaceuticals and assays using enzyme subunits
12/13/2005US6974595 Pharmaceutical compositions based on Diclofenae
12/13/2005US6974594 Method of preparing biological materials and preparations produced using same
12/13/2005US6974593 Spraying a compressed fluid comprising a water insoluble active material in solvent, into an aqueous solution comprising a surfactant, forming microparticles; increase the drug bioavailability
12/13/2005US6974592 Exterior shell; drug delivery; storage stability
12/13/2005US6974591 Suspending a pore-forming agent in an aqueous dispersion of a film-forming, water insoluble polymer to form a coating suspension having solid particles of pore former suspended therein, and coating a drug-containing solid core, drying
12/13/2005US6974590 Sublingual buccal effervescent
12/13/2005US6974589 Neutral-cationic lipid for nucleic acid and drug delivery
12/13/2005US6974588 Transdermal patch for delivering volatile liquid drugs
12/13/2005US6974587 Sustained release of drug; fluid bladder; hermetic sealing; pressurization
12/13/2005US6974585 Film-forming cyanoacrylate with mixture of antibiotics for forming antibiotic containing film in situ over mammalian tissue
12/13/2005US6974568 Treatment for cough
12/13/2005US6974567 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
12/13/2005US6974448 Method for convection enhanced delivery catheter to treat brain and other tumors
12/13/2005US6974445 Implantable medical device for delivering a liquid
12/13/2005US6974437 Microprocessor controlled ambulatory medical apparatus with hand held communication device
12/13/2005US6973741 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
12/13/2005US6973718 Methods for conformal coating and sealing microchip reservoir devices
12/13/2005CA2442479C Topical compositions for prostaglandin e1 delivery
12/13/2005CA2435729C New film coating
12/13/2005CA2324403C Lipophilic microparticles containing a protein drug or antigen and formulation comprising same
12/13/2005CA2278521C Two phase skin preparations comprising lipophilic and hydrophilic components
12/13/2005CA2256596C Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
12/13/2005CA2147274C Transdermal therapeutic system for administering physostigmin through the skin, and method of producing the system
12/08/2005WO2005116212A2 Treatment of neurodegenerative disease through intracranial delivery of sirna
12/08/2005WO2005116131A1 A dried and agglomerated hyaluronic acid product
12/08/2005WO2005116130A1 A fast dissolving dried hyaluronic acid product
12/08/2005WO2005115484A1 Use in the medical, diagnostic and phlebological field of a mixture of sterile and physiologically acceptable gases
12/08/2005WO2005115475A1 Thickener for ophthalmic use
12/08/2005WO2005115474A1 Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
12/08/2005WO2005115473A2 Nutritional food and feed, composition, processing and method of use
12/08/2005WO2005115441A2 Compositions and methods for enhanced mucosal delivery of parathyroid hormone
12/08/2005WO2005115430A1 Treatment of inflammatory airway disease
12/08/2005WO2005115418A2 New hydroxapatite calcium phosphates, their method of preparation and their applications
12/08/2005WO2005115387A1 Sustained release composition for oral administration of niacin
12/08/2005WO2005115377A1 Functional foods comprising flavonoids and tocotrienols and methods thereof
12/08/2005WO2005115360A2 Formulations of anti-pain agents and methods of using the same
12/08/2005WO2005115358A2 Intranasal delivery of nucleic acid molecules
12/08/2005WO2005115356A2 Anti-microbial handle system
12/08/2005WO2005115355A1 Pasting preparation
12/08/2005WO2005115354A2 Compositions and methods for bone formation and remodeling
12/08/2005WO2005115353A1 Pharmaceutical suspension composition
12/08/2005WO2005115352A1 Dry-coating process
12/08/2005WO2005115351A1 Hormonal contraceptive containing a combination of ethinyl estradiol and chlormadinone acetate
12/08/2005WO2005115350A1 Hormonal contraceptive containing a combination of ethinyl estradiol and chlormadinone acetate
12/08/2005WO2005115349A1 Folic acid-containing contraceptive
12/08/2005WO2005115348A1 Tablets exhibiting reduced drug release variability
12/08/2005WO2005115347A1 Dispersible tablet comprising beta lactam antibiotics and process for preparing the same
12/08/2005WO2005115346A2 Pharmaceutical composition containing risperidone
12/08/2005WO2005115345A1 Oral therapeutic compound delivery system
12/08/2005WO2005115344A1 Oral delivery system
12/08/2005WO2005115343A2 Formulation obtained from a powder mixture comprising an inorganic pigment
12/08/2005WO2005115342A1 Particulate comprising a calcium-containing compound and a sugar alcohol
12/08/2005WO2005115341A2 Microparticles for oral delivery
12/08/2005WO2005115340A1 Micropellet containing pellets and method of preparing such pellets
12/08/2005WO2005115339A2 Composition for enhancing absorption of a drug and method
12/08/2005WO2005115338A2 Macromolecular gsh-activated glyoxylase i inhibitors
12/08/2005WO2005115337A1 Superloaded liposomes for drug delivery
12/08/2005WO2005115336A2 Sprayable formulations for the treatment of acute inflammatory skin conditions
12/08/2005WO2005115335A1 Spot-on formulation useful for cosmetology and dermatology
12/08/2005WO2005115333A2 A biomolecule-containing formulation of increased stability
12/08/2005WO2005115332A2 Heat sterilization of glucocorticosteroids
12/08/2005WO2005115331A2 Enteric solid oral dosage form of bisphosphonate containing a chelating agent
12/08/2005WO2005115330A2 Pharmaceutical compositions with enhanced performance
12/08/2005WO2005115318A2 Method for thickening hair and hair thickener
12/08/2005WO2005115110A2 Oral products
12/08/2005WO2005104648A3 Pegylated nanoparticles
12/08/2005WO2005099713A3 Novel antiviral pharmaceutical composition
12/08/2005WO2005097073A8 Macromolecular delivery systems for non-invasive imaging, evaluation and treatment of arthritis and other inflammatory diseases
12/08/2005WO2005092039A3 Crosslinked amine polymers
12/08/2005WO2005084650A9 Pharmaceutical composition for topical use in form of xerogels or films and methods for production
12/08/2005WO2005082428A3 Plaster that reduces skin irritation